Purpose: We report a study of encapsulation and release from solid lipid microparticles (SLMs) of a prodrug of zidovudine (AZT), an antiviral agent, obtained by its ester conjiugation with a bile acid, the ursodeoxycholic acid (UDCA). We have demonstrated that this prodrug is able to elude the active efflux systems expressed on physiological barriers. Results: The mean diameters of tristerain and stearic acid loaded microparticles were 7 and 14 micron, respectively. The shape of the SLMs was spherical and their prodrug loading was 0.57% (tristearin based) and 1.84% (stearic acid based). The tristearin SLMs were able to control the release of the prodrug, whereas the stearic acid SLMs induced a significant increase of the dissolution rate of the free prodrug obtained in the presence of Twwen 60. Conclusions. The developed SLMs were represent a good candidate for the local delivery of UDCA-AZT in the nose and its potential uptake in the brain.
Solid Lipid Nanoparticles for the sustained release of a prodrug of Zidovudine by its conjugation with ursodeoxycholic acid / A., Dalpiaz; Leo, Eliana Grazia; Iannuccelli, Valentina; S., Scalia. - STAMPA. - 1:(2013), pp. 132-132. (Intervento presentato al convegno 3rd Conference on innovation in drug delivery: advances in local drug delivery tenutosi a Pisa nel 22-25 settembre 2013).
Solid Lipid Nanoparticles for the sustained release of a prodrug of Zidovudine by its conjugation with ursodeoxycholic acid
LEO, Eliana Grazia;IANNUCCELLI, Valentina;
2013
Abstract
Purpose: We report a study of encapsulation and release from solid lipid microparticles (SLMs) of a prodrug of zidovudine (AZT), an antiviral agent, obtained by its ester conjiugation with a bile acid, the ursodeoxycholic acid (UDCA). We have demonstrated that this prodrug is able to elude the active efflux systems expressed on physiological barriers. Results: The mean diameters of tristerain and stearic acid loaded microparticles were 7 and 14 micron, respectively. The shape of the SLMs was spherical and their prodrug loading was 0.57% (tristearin based) and 1.84% (stearic acid based). The tristearin SLMs were able to control the release of the prodrug, whereas the stearic acid SLMs induced a significant increase of the dissolution rate of the free prodrug obtained in the presence of Twwen 60. Conclusions. The developed SLMs were represent a good candidate for the local delivery of UDCA-AZT in the nose and its potential uptake in the brain.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
